{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,26]],"date-time":"2026-09-26T11:52:00Z","timestamp":1790423520335,"version":"4.1.0"},"reference-count":55,"publisher":"Elsevier BV","issue":"1","license":[{"start":{"date-parts":[[2008,3,1]],"date-time":"2008-03-01T00:00:00Z","timestamp":1204329600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2008,3,1]],"date-time":"2008-03-01T00:00:00Z","timestamp":1204329600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","theclinics.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Endocrinology and Metabolism Clinics of North America"],"published-print":{"date-parts":[[2008,3]]},"DOI":"10.1016\/j.ecl.2007.10.010","type":"journal-article","created":{"date-parts":[[2008,1,28]],"date-time":"2008-01-28T13:29:27Z","timestamp":1201526967000},"page":"135-149","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":167,"title":["Cushing's Syndrome"],"prefix":"10.1016","volume":"37","author":[{"given":"Rosario","family":"Pivonello","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Maria Cristina","family":"De Martino","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Monica","family":"De Leo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gaetano","family":"Lombardi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Annamaria","family":"Colao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.ecl.2007.10.010_bib1","doi-asserted-by":"crossref","first-page":"1605","DOI":"10.1016\/S0140-6736(06)68699-6","article-title":"Cushing's syndrome","volume":"367","author":"Newell-Price","year":"2006","journal-title":"Lancet"},{"key":"10.1016\/j.ecl.2007.10.010_bib2","first-page":"117","article-title":"Incidence and late prognosis of Cushing's syndrome: a population-based study","volume":"86","author":"Lindholm","year":"2001","journal-title":"Clin Endocrinol Metab"},{"key":"10.1016\/j.ecl.2007.10.010_bib3","doi-asserted-by":"crossref","first-page":"5808","DOI":"10.1210\/jc.2003-030254","article-title":"Occult Cushing's syndrome in type-2 diabetes","volume":"88","author":"Catargi","year":"2003","journal-title":"J Clin Endocrinol Metab"},{"key":"10.1016\/j.ecl.2007.10.010_bib4","doi-asserted-by":"crossref","first-page":"1554","DOI":"10.1210\/jc.2002-021518","article-title":"Gender-related differences in the presentation and course of Cushing's disease","volume":"88","author":"Pecori Giraldi","year":"2003","journal-title":"J Clin Endocrinol Metab"},{"key":"10.1016\/j.ecl.2007.10.010_bib5","doi-asserted-by":"crossref","first-page":"327","DOI":"10.1016\/j.ecl.2005.01.010","article-title":"The metabolic syndrome and cardiovascular risk in Cushing's syndrome","volume":"34","author":"Pivonello","year":"2005","journal-title":"Endocrinol Metab Clin North Am"},{"key":"10.1016\/j.ecl.2007.10.010_bib6","doi-asserted-by":"crossref","DOI":"10.1210\/jc.2002-021558","article-title":"Cardiovascular risk factors and common carotid artery caliber and stiffness in patients with Cushing's disease during active disease and 1 year after disease remission","volume":"88","author":"Faggiano","year":"2003","journal-title":"J Clin Endocrinol Metab"},{"key":"10.1016\/j.ecl.2007.10.010_bib7","doi-asserted-by":"crossref","first-page":"6616","DOI":"10.1210\/jc.2005-0656","article-title":"Sulfur amino acids in Cushing's disease: insight in homocysteine and taurine levels in patients with active and cured disease","volume":"90","author":"Faggiano","year":"2005","journal-title":"J Clin Endocrinol Metab"},{"key":"10.1016\/j.ecl.2007.10.010_bib8","first-page":"2664","article-title":"Persistence of increased cardiovascular risk in patients with Cushing's disease after five years of successful cure","volume":"84","author":"Colao","year":"1999","journal-title":"J Clin Endocrinol Metab"},{"key":"10.1016\/j.ecl.2007.10.010_bib9","doi-asserted-by":"crossref","first-page":"2076","DOI":"10.1210\/jc.2002-021494","article-title":"Nephrolithiasis in Cushing's disease: prevalence, etiopathogenesis, and modification after disease cure","volume":"88","author":"Faggiano","year":"2003","journal-title":"J Clin Endocrinol Metab"},{"key":"10.1016\/j.ecl.2007.10.010_bib10","doi-asserted-by":"crossref","first-page":"153","DOI":"10.1046\/j.0300-0664.2001.01454.doc.x","article-title":"Severe impairment of bone mass and turnover in Cushing's disease: comparison between childhood-onset and adulthood-onset disease","volume":"56","author":"Di Somma","year":"2002","journal-title":"Clin Endocrinol (Oxf)"},{"key":"10.1016\/j.ecl.2007.10.010_bib11","doi-asserted-by":"crossref","first-page":"1779","DOI":"10.1210\/jc.2005-0582","article-title":"Bone demineralization and vertebral fractures in endogenous cortisol excess: role of disease etiology and gonadal status","volume":"91","author":"Tauchmanov\u00e0","year":"2006","journal-title":"J Clin Endocrinol Metab"},{"key":"10.1016\/j.ecl.2007.10.010_bib12","doi-asserted-by":"crossref","first-page":"655","DOI":"10.1046\/j.1365-2265.1998.00486.x","article-title":"Effectiveness of chronic treatment with alendronate in the osteoporosis of Cushing's disease","volume":"48","author":"Di Somma","year":"1998","journal-title":"Clin Endocrinol (Oxf)"},{"key":"10.1016\/j.ecl.2007.10.010_bib13","doi-asserted-by":"crossref","first-page":"367","DOI":"10.1016\/S0306-4530(01)00059-2","article-title":"Persistent cognitive impairment following surgical treatment of Cushing's syndrome","volume":"27","author":"Forget","year":"2002","journal-title":"Psychoneuroendocrinology"},{"key":"10.1016\/j.ecl.2007.10.010_bib14","first-page":"1949","article-title":"Loss of brain volume in endogenous Cushing's syndrome and its reversibility after correction of hypercortisolism","volume":"87","author":"Bourdeau","year":"2002","journal-title":"J Clin Endocrinol Metab"},{"key":"10.1016\/j.ecl.2007.10.010_bib15","doi-asserted-by":"crossref","first-page":"447","DOI":"10.1210\/jc.2005-1058","article-title":"Long-term impaired quality of life in Cushing's syndrome despite initial improvement after surgical remission","volume":"91","author":"Lindsay","year":"2006","journal-title":"J Clin Endocrinol Metab"},{"key":"10.1016\/j.ecl.2007.10.010_bib16","doi-asserted-by":"crossref","first-page":"5593","DOI":"10.1210\/jc.2003-030871","article-title":"Diagnosis and complications of Cushing's syndrome: a consensus statement","volume":"88","author":"Arnaldi","year":"2003","journal-title":"J Clin Endocrinol Metab"},{"key":"10.1016\/j.ecl.2007.10.010_bib17","first-page":"647","article-title":"The diagnosis and differential diagnosis of Cushing's syndrome and pseudo-Cushing's states","volume":"19","author":"Newell-Price","year":"1998","journal-title":"Endocr Rev"},{"key":"10.1016\/j.ecl.2007.10.010_bib18","doi-asserted-by":"crossref","first-page":"3045","DOI":"10.1001\/archinte.160.20.3045","article-title":"The diagnosis of Cushing's syndrome: atypical presentations and laboratory shortcomings","volume":"160","author":"Boscaro","year":"2000","journal-title":"Arch Intern Med"},{"key":"10.1016\/j.ecl.2007.10.010_bib19","doi-asserted-by":"crossref","first-page":"4515","DOI":"10.1210\/jc.2002-020534","article-title":"Nighttime salivary cortisol: a useful test for the diagnosis of Cushing's syndrome","volume":"87","author":"Papanicolaou","year":"2002","journal-title":"J Clin Endocrinol Metab"},{"key":"10.1016\/j.ecl.2007.10.010_bib20","doi-asserted-by":"crossref","first-page":"2232","DOI":"10.1001\/jama.1993.03500170062035","article-title":"Corticotropin-releasing hormone stimulation following low-dose dexamethasone administration. A new test to distinguish Cushing's syndrome from pseudo-Cushing's states","volume":"269","author":"Yanovski","year":"1993","journal-title":"JAMA"},{"key":"10.1016\/j.ecl.2007.10.010_bib21","doi-asserted-by":"crossref","first-page":"251","DOI":"10.1111\/j.1365-2265.2006.02717.x","article-title":"The dexamethasone-suppressed corticotropin-releasing hormone stimulation test and the desmopressin test to distinguish Cushing's syndrome from pseudo-Cushing's states","volume":"66","author":"Pecori Giraldi","year":"2007","journal-title":"Clin Endocrinol (Oxf)"},{"key":"10.1016\/j.ecl.2007.10.010_bib22","first-page":"440","article-title":"Diagnosis and management of Cushing's syndrome: results of an Italian multicentre study. Study Group of the Italian Society of Endocrinology on the Pathophysiology of the Hypothalamic-Pituitary-Adrenal Axis","volume":"84","author":"Invitti","year":"1999","journal-title":"J Clin Endocrinol Metab"},{"key":"10.1016\/j.ecl.2007.10.010_bib23","doi-asserted-by":"crossref","first-page":"897","DOI":"10.1056\/NEJM199109263251301","article-title":"Petrosal sinus sampling with and without corticotropin-releasing hormone for the differential diagnosis of Cushing's syndrome","volume":"325","author":"Oldfield","year":"1991","journal-title":"N Engl J Med"},{"key":"10.1016\/j.ecl.2007.10.010_bib24","doi-asserted-by":"crossref","first-page":"499","DOI":"10.1530\/eje.0.1440499","article-title":"Study Group of the Italian Endocrinology Society on the Pathophsiology of the Hypothalamic-Pituitary-Adrenal Axis. Inferior petrosal sinus sampling in the differential diagnosis of Cushing's syndrome: results of an Italian multicenter study","volume":"144","author":"Colao","year":"2001","journal-title":"Eur J Endocrinol"},{"key":"10.1016\/j.ecl.2007.10.010_bib25","doi-asserted-by":"crossref","first-page":"541","DOI":"10.1046\/j.1365-2265.2002.01511.x","article-title":"Long-term follow-up results of transsphenoidal surgery for Cushing's disease in a single centre using strict criteria for remission","volume":"56","author":"Rees","year":"2002","journal-title":"Clin Endocrinol (Oxf)"},{"key":"10.1016\/j.ecl.2007.10.010_bib26","doi-asserted-by":"crossref","first-page":"549","DOI":"10.1111\/j.1365-2265.2005.02380.x","article-title":"Long-term remission rates after pituitary surgery for Cushing's disease: the need for long-term surveillance","volume":"63","author":"Atkinson","year":"2005","journal-title":"Clinical Endocrinol (Oxf)"},{"key":"10.1016\/j.ecl.2007.10.010_bib27","doi-asserted-by":"crossref","first-page":"5858","DOI":"10.1210\/jc.2003-030751","article-title":"Long-term predictive value of postsurgical cortisol concentrations for cure and risk of recurrence in Cushing's disease","volume":"88","author":"Pereira","year":"2003","journal-title":"J Clin Endocrinol Metab"},{"key":"10.1016\/j.ecl.2007.10.010_bib28","doi-asserted-by":"crossref","first-page":"25","DOI":"10.1046\/j.0300-0664.2001.01444.x","article-title":"Undetectable postoperative cortisol does not always predict long-term remission in Cushing's disease: a single centre audit","volume":"56","author":"Yap","year":"2002","journal-title":"Clin Endocrinol (Oxf)"},{"key":"10.1016\/j.ecl.2007.10.010_bib29","doi-asserted-by":"crossref","first-page":"654","DOI":"10.1007\/BF03347498","article-title":"Bilateral adrenalectomy for Cushing's syndrome: a comparison between laparoscopy and open surgery","volume":"27","author":"Porpiglia","year":"2004","journal-title":"J Endocrinol Invest"},{"key":"10.1016\/j.ecl.2007.10.010_bib30","doi-asserted-by":"crossref","first-page":"209","DOI":"10.1007\/s11102-005-1403-y","article-title":"The Nelson's syndrome revisited","volume":"7","author":"Assie","year":"2004","journal-title":"Pituitary"},{"key":"10.1016\/j.ecl.2007.10.010_bib31","doi-asserted-by":"crossref","first-page":"443","DOI":"10.1210\/edrv-14-4-443","article-title":"The medical treatment of Cushing's syndrome","volume":"14","author":"Miller","year":"1993","journal-title":"Endocr Rev"},{"key":"10.1016\/j.ecl.2007.10.010_bib32","doi-asserted-by":"crossref","first-page":"77","DOI":"10.1023\/A:1022308429992","article-title":"Medical therapy of Cushing's disease","volume":"5","author":"Nieman","year":"2002","journal-title":"Pituitary"},{"key":"10.1016\/j.ecl.2007.10.010_bib33","doi-asserted-by":"crossref","first-page":"811","DOI":"10.1016\/S0140-6736(76)90656-5","article-title":"Bromocriptine in Nelson's syndrome and Cushing's disease","volume":"2","author":"Lamberts","year":"1976","journal-title":"Lancet"},{"key":"10.1016\/j.ecl.2007.10.010_bib34","doi-asserted-by":"crossref","first-page":"307","DOI":"10.1210\/jcem-51-2-307","article-title":"The mechanism of the suppressive action of bromocriptine on adrenocorticotropin secretion in patients with Cushing's disease and Nelson's syndrome","volume":"51","author":"Lamberts","year":"1980","journal-title":"J Clin Endocrinol Metab"},{"key":"10.1016\/j.ecl.2007.10.010_bib35","doi-asserted-by":"crossref","first-page":"266","DOI":"10.1055\/s-0029-1211361","article-title":"Effect of injectable bromocriptine in patients with Cushing's disease","volume":"103","author":"Invitti","year":"1995","journal-title":"Exp Clin Endocrinol Diabetes"},{"key":"10.1016\/j.ecl.2007.10.010_bib36","doi-asserted-by":"crossref","first-page":"1281","DOI":"10.1038\/nm784","article-title":"Functional PPARgamma receptor is a novel therapeutic target for ACTH-secreting pituitary adenomas","volume":"8","author":"Heaney","year":"2002","journal-title":"Nat Med"},{"key":"10.1016\/j.ecl.2007.10.010_bib37","doi-asserted-by":"crossref","first-page":"1381","DOI":"10.1172\/JCI200316575","article-title":"PPAR-gamma receptor ligands: novel therapy for pituitary adenomas","volume":"111","author":"Heaney","year":"2003","journal-title":"J Clin Invest"},{"key":"10.1016\/j.ecl.2007.10.010_bib38","doi-asserted-by":"crossref","first-page":"173","DOI":"10.1530\/eje.0.1510173","article-title":"Effects of chronic administration of PPAR-gamma ligand rosiglitazone in Cushing's disease","volume":"151","author":"Ambrosi","year":"2004","journal-title":"Eur J Endocrinol"},{"key":"10.1016\/j.ecl.2007.10.010_bib39","doi-asserted-by":"crossref","first-page":"219","DOI":"10.1111\/j.1365-2265.2006.02452.x","article-title":"Effect of protracted treatment with rosiglitazone, a PPARgamma agonist, in patients with Cushing's disease","volume":"64","author":"Pecori Giraldi","year":"2006","journal-title":"Clin Endocrinol (Oxf)"},{"key":"10.1016\/j.ecl.2007.10.010_bib40","doi-asserted-by":"crossref","first-page":"1340","DOI":"10.1210\/jc.2004-1746","article-title":"Effect of pioglitazone on adrenocorticotropic hormone and cortisol secretion in Cushing's disease","volume":"90","author":"Suri","year":"2005","journal-title":"J Clin Endocrinol Metab"},{"key":"10.1016\/j.ecl.2007.10.010_bib41","doi-asserted-by":"crossref","first-page":"1758","DOI":"10.1210\/jc.2006-2005","article-title":"Ineffectiveness of rosiglitazone therapy in Nelson's syndrome","volume":"92","author":"Munir","year":"2007","journal-title":"J Clin Endocrinol Metab"},{"key":"10.1016\/j.ecl.2007.10.010_bib42","doi-asserted-by":"crossref","first-page":"51","DOI":"10.1530\/eje.0.1440051","article-title":"ACTH silent adenoma shrinking under cabergoline","volume":"144","author":"Petrossians","year":"2001","journal-title":"Eur J Endocrinol"},{"key":"10.1016\/j.ecl.2007.10.010_bib43","doi-asserted-by":"crossref","first-page":"172","DOI":"10.1007\/BF03343983","article-title":"Macroprolactinoma associated with Cushing's disease, successfully treated with cabergoline","volume":"25","author":"T'Sjoen","year":"2002","journal-title":"J Endocrinol Invest"},{"key":"10.1016\/j.ecl.2007.10.010_bib44","doi-asserted-by":"crossref","first-page":"2452","DOI":"10.1210\/jc.2003-030837","article-title":"Dopamine receptor expression and function in corticotroph pituitary tumors","volume":"89","author":"Pivonello","year":"2004","journal-title":"J Clin Endocrinol Metab"},{"key":"10.1016\/j.ecl.2007.10.010_bib45","unstructured":"Pivonello R, De Martino MC, Faggiano A, et\u00a0al. Cabergoline treatment in Cushing's disease: effect on hypertension, glucose metabolism and dyslipidemia. Presented at the 9th European Congress of Endocrinology, Budapest, Hungary, April 29\u2013May 2, 2007."},{"key":"10.1016\/j.ecl.2007.10.010_bib46","doi-asserted-by":"crossref","first-page":"860","DOI":"10.1007\/BF03343660","article-title":"Complete remission of Nelson's syndrome after 1-year treatment with cabergoline","volume":"22","author":"Pivonello","year":"1999","journal-title":"J Endocrinol Invest"},{"key":"10.1016\/j.ecl.2007.10.010_bib47","first-page":"300","article-title":"Nelson's syndrome: complete remission with cabergoline but not with bromocriptine or cyproheptadine treatment","volume":"62","author":"Casulari","year":"2004","journal-title":"Horm Res"},{"key":"10.1016\/j.ecl.2007.10.010_bib48","doi-asserted-by":"crossref","first-page":"151","DOI":"10.1007\/s11102-006-9290-4","article-title":"Clinical and biochemical stabilization of Nelson's syndrome with long-term low-dose cabergoline treatment. Clinical and biochemical stabilization of Nelson's syndrome with long-term low-dose cabergoline treatment","volume":"9","author":"Shraga-Slutzky","year":"2006","journal-title":"Pituitary"},{"key":"10.1016\/j.ecl.2007.10.010_bib49","doi-asserted-by":"crossref","first-page":"645","DOI":"10.1530\/eje.1.01876","article-title":"The multi-ligand somatostatin analogue SOM230 inhibits ACTH secretion by cultured human corticotroph adenomas via somatostatin receptor type 5","volume":"152","author":"Hofland","year":"2005","journal-title":"Eur J Endocrinol"},{"key":"10.1016\/j.ecl.2007.10.010_bib50","unstructured":"Boscaro M, Atkinson A, Bertherat J, et\u00a0al. SOM230 Cushing's disease study group. Early data on the efficacy and safety of the novel multi-ligand somatostatin analog, SOM230, in patients with Cushing's disease. Presented at the 87th Annual Meeting of the Endocrine Society. San Diego (CA), June 4\u20137, 2005."},{"key":"10.1016\/j.ecl.2007.10.010_bib51","doi-asserted-by":"crossref","first-page":"2457","DOI":"10.1056\/NEJM200506093522322","article-title":"Cabergoline plus lanreotide for ectopic Cushing's syndrome","volume":"352","author":"Pivonello","year":"2005","journal-title":"N Engl J Med"},{"key":"10.1016\/j.ecl.2007.10.010_bib52","doi-asserted-by":"crossref","first-page":"66","DOI":"10.1210\/jc.2006-0728","article-title":"Dopamine receptor expression and function in corticotroph ectopic tumors","volume":"92","author":"Pivonello","year":"2007","journal-title":"J Clin Endocrinol Metab"},{"key":"10.1016\/j.ecl.2007.10.010_bib53","doi-asserted-by":"crossref","first-page":"1123","DOI":"10.1172\/JCI11098","article-title":"Retinoic acid prevents experimental Cushing syndrome","volume":"108","author":"Paez-Pereda","year":"2001","journal-title":"J Clin Invest"},{"key":"10.1016\/j.ecl.2007.10.010_bib54","doi-asserted-by":"crossref","first-page":"172","DOI":"10.1056\/NEJM199701163360303","article-title":"The long-term outcome of pituitary irradiation after unsuccessful transsphenoidal surgery in Cushing's disease","volume":"336","author":"Estrada","year":"1997","journal-title":"N Engl J Med"},{"key":"10.1016\/j.ecl.2007.10.010_bib55","doi-asserted-by":"crossref","first-page":"738","DOI":"10.3171\/jns.2000.93.5.0738","article-title":"Radiosurgery for Cushing's disease after failed transsphenoidal surgery","volume":"93","author":"Sheehan","year":"2000","journal-title":"J Neurosurg"}],"container-title":["Endocrinology and Metabolism Clinics of North America"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0889852907000977?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0889852907000977?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,11]],"date-time":"2025-10-11T09:30:39Z","timestamp":1760175039000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0889852907000977"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2008,3]]},"references-count":55,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2008,3]]}},"alternative-id":["S0889852907000977"],"URL":"https:\/\/doi.org\/10.1016\/j.ecl.2007.10.010","relation":{},"ISSN":["0889-8529"],"issn-type":[{"value":"0889-8529","type":"print"}],"subject":[],"published":{"date-parts":[[2008,3]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Cushing's Syndrome","name":"articletitle","label":"Article Title"},{"value":"Endocrinology and Metabolism Clinics of North America","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.ecl.2007.10.010","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2008 Elsevier Inc. All rights reserved.","name":"copyright","label":"Copyright"}]}}